India's Unichem Laboratories up after deal to buy Bayshore USA's assets
** Shares of Unichem Laboratories UNLB.NS up 3.5% at 681.1
rupees
** Specialty pharmaceutical co enters agreements to purchase
all rights in product approvals and goodwill associated with
nine abbreviated new drug applications (ANDA) of Bayshore USA
for $2.7 million
** Co's U.S. unit to buy U.S. generics formulations
marketing/distribution business of Bayshore USA for $10 million
** Stock up 67% YTD
(Reporting by Aleef Jahan in Bengaluru)
((aleefjahan.cs@thomsonreuters.com))
Recent news on Unichem Laboratories
See all newsIndia's Unichem Laboratories drops after US FDA inspection ends with five observations
India's Unichem Labs falls after appeal against tax demand rejected
Brief: Unichem Laboratories June-Quarter Consol PAT 414.7 Million Rupees
India's Unichem Laboratories jumps on posting Q1 profit
India's Unichem Laboratories surges in busiest session ever after block deal at premium